| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma
|
Frusteri, Cristina
|
|
|
103 |
12 |
p. 6035-6037
|
artikel
|
| 2 |
A case of visual impairment due to HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2 subtype
|
Pan, Yan-sha
|
|
|
103 |
12 |
p. 5973-5979
|
artikel
|
| 3 |
Adipopenia is associated with poor outcomes in elderly patients with B-cell lymphoma
|
Kadota, Saori
|
|
|
103 |
12 |
p. 6021-6023
|
artikel
|
| 4 |
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma
|
Hu, Weiwen
|
|
|
103 |
12 |
p. 5085-5101
|
artikel
|
| 5 |
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche
|
Deng, Ju
|
|
|
103 |
12 |
p. 5035-5057
|
artikel
|
| 6 |
A girl with a novel nonsense mutation in Chediak-Higashi syndrome was relieved successfully by treatment with HCST and UCBT: a case report
|
CanLiu,
|
|
|
103 |
12 |
p. 5957-5961
|
artikel
|
| 7 |
Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia
|
Sugita, Junichi
|
|
|
103 |
12 |
p. 4851-4868
|
artikel
|
| 8 |
All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations
|
Sánchez-Mendoza, Silvia Elena
|
|
|
103 |
12 |
p. 5405-5416
|
artikel
|
| 9 |
Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma
|
Cancilla, Daniel
|
|
|
103 |
12 |
p. 6027-6030
|
artikel
|
| 10 |
Analysis of CCND3 mutations in diffuse large B-cell lymphoma
|
Hua, Wei
|
|
|
103 |
12 |
p. 5729-5739
|
artikel
|
| 11 |
Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms
|
Cahuapaza-Gutierrez, Nelson Luis
|
|
|
103 |
12 |
p. 4989-5005
|
artikel
|
| 12 |
Application of allogeneic hematopoietic stem cell transplantation to treat Behcet’s disease with myelodysplastic syndrome: a case report and literature review
|
Lei, RuiQi
|
|
|
103 |
12 |
p. 6015-6020
|
artikel
|
| 13 |
A simplified geriatric prognostic index to survival in older Asian patients with diffuse large B-Cell lymphoma treated with standard chemo-immunotherapy
|
Lim, Nicole-Ann
|
|
|
103 |
12 |
p. 5663-5671
|
artikel
|
| 14 |
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL
|
Mijiti, Mutibaier
|
|
|
103 |
12 |
p. 5627-5638
|
artikel
|
| 15 |
Association of albumin to urea nitrogen ratio with 30-day mortality in adult hemophagocytic lymphohistiocytosis: a retrospective cohort study
|
Zhou, Jun
|
|
|
103 |
12 |
p. 5103-5112
|
artikel
|
| 16 |
Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms
|
Min, Gi-June
|
|
|
103 |
12 |
p. 5261-5272
|
artikel
|
| 17 |
Broadening perspectives: redefining the role of obesity in ITP
|
Liang, Chenglong
|
|
|
103 |
12 |
p. 6025-6026
|
artikel
|
| 18 |
Case report:Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia
|
Wang, Nan
|
|
|
103 |
12 |
p. 5941-5944
|
artikel
|
| 19 |
Case report: VEXAS syndrome with excellent response to treatment with azacitidine
|
Porges, Tzvika
|
|
|
103 |
12 |
p. 5935-5939
|
artikel
|
| 20 |
CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia
|
Yao, Yao
|
|
|
103 |
12 |
p. 6031-6033
|
artikel
|
| 21 |
Central nervous system relapse after allogeneic HCT in FLT3-mutated AML
|
Kouidri, Khouloud
|
|
|
103 |
12 |
p. 5387-5393
|
artikel
|
| 22 |
Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation
|
Liu, Fang-Tong
|
|
|
103 |
12 |
p. 6003-6006
|
artikel
|
| 23 |
Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis
|
Ali, Haadi
|
|
|
103 |
12 |
p. 5123-5144
|
artikel
|
| 24 |
Clinical characteristics and prognostic analysis of pediatric hemophagocytic lymphohistiocytosis using lasso-logistic regression
|
Luo, Nandu
|
|
|
103 |
12 |
p. 5191-5200
|
artikel
|
| 25 |
Clinical data and MRI features-based nomogram for differentiation of central nervous system infection and central nervous system involvement in hematological malignancy
|
Yi, Huiming
|
|
|
103 |
12 |
p. 5915-5923
|
artikel
|
| 26 |
Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH)
|
Zhao, Yunze
|
|
|
103 |
12 |
p. 5201-5211
|
artikel
|
| 27 |
Clonal evolution defines risk stratification for central nervous system leukemia in adult acute lymphoblastic leukemia
|
Li, Jia
|
|
|
103 |
12 |
p. 5759-5767
|
artikel
|
| 28 |
Comparative analysis of somatic mutations in MYD88, CD79B, CARD11, and BTK between gastric marginal zone B-cell lymphoma of MALT and diffuse large B-cell lymphoma
|
Dugge, Rucha
|
|
|
103 |
12 |
p. 6057-6058
|
artikel
|
| 29 |
Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
|
Wen, Xiaolian
|
|
|
103 |
12 |
p. 5527-5537
|
artikel
|
| 30 |
Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes
|
Bin, Ting
|
|
|
103 |
12 |
p. 5297-5314
|
artikel
|
| 31 |
Correction to: A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs
|
Ma, Fuxin
|
|
|
103 |
12 |
p. 6059
|
artikel
|
| 32 |
Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
|
Fleischmann, Maximilian
|
|
|
103 |
12 |
p. 6061
|
artikel
|
| 33 |
COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses
|
Dawudi, Yachar
|
|
|
103 |
12 |
p. 5071-5083
|
artikel
|
| 34 |
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience
|
Mele, Giuseppe
|
|
|
103 |
12 |
p. 5691-5701
|
artikel
|
| 35 |
Detection methods and prognosis implications of measurable residual disease in acute myeloid leukemia
|
Zhao, Zihan
|
|
|
103 |
12 |
p. 4869-4881
|
artikel
|
| 36 |
Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients
|
Yang, Tianshuo
|
|
|
103 |
12 |
p. 5583-5598
|
artikel
|
| 37 |
Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time
|
Scalzulli, Emilia
|
|
|
103 |
12 |
p. 5377-5386
|
artikel
|
| 38 |
Distinct clinical profiles and patient outcomes in aCML and CNL
|
Sun, Yingxin
|
|
|
103 |
12 |
p. 5325-5332
|
artikel
|
| 39 |
Distinct pathway activities are associated with prognosis and response to bortezomib-containing treatment in MCL1-M based molecular subtypes of multiple myeloma
|
Yang, Yuan
|
|
|
103 |
12 |
p. 5495-5510
|
artikel
|
| 40 |
DNMT3A-R882: a mutation with many paradoxes
|
Jafari, Pourya Arbab
|
|
|
103 |
12 |
p. 4981-4988
|
artikel
|
| 41 |
Donor selection for allogeneic hematopoietic cell transplant in a patient with JAK2 V617F primary myelofibrosis and SH2B3/LNK germline variant
|
Ranucci, Giorgia
|
|
|
103 |
12 |
p. 5999-6002
|
artikel
|
| 42 |
Effects of different doses of rituximab on immunoglobulin levels in high-risk pediatrics with Burkitt’s lymphoma
|
Huang, Shuang
|
|
|
103 |
12 |
p. 5807-5816
|
artikel
|
| 43 |
Efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: a systematic review and meta-analysis
|
Qureshi, Zaheer
|
|
|
103 |
12 |
p. 4901-4912
|
artikel
|
| 44 |
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study
|
Nakamura, Naokazu
|
|
|
103 |
12 |
p. 5681-5690
|
artikel
|
| 45 |
Efficacy of thiotepa-conditioned autologous stem-cell transplantation as consolidation therapy for primary leptomeningeal malignant lymphoma: a case report and review of literature
|
Shimada, Tomohito
|
|
|
103 |
12 |
p. 5951-5955
|
artikel
|
| 46 |
Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group
|
Monsereenusorn, Chalinee
|
|
|
103 |
12 |
p. 5461-5472
|
artikel
|
| 47 |
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease
|
Motta, Irene
|
|
|
103 |
12 |
p. 5113-5121
|
artikel
|
| 48 |
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry
|
Mathur, S.
|
|
|
103 |
12 |
p. 5241-5248
|
artikel
|
| 49 |
Flow cytometric expression of Bcl-2, Mcl-1, and their ratios correlates with primary and secondary cytogenetic changes and their combinations in multiple myeloma
|
Singla, Shelly
|
|
|
103 |
12 |
p. 5473-5481
|
artikel
|
| 50 |
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML
|
Matsukawa, Toshihiro
|
|
|
103 |
12 |
p. 5333-5340
|
artikel
|
| 51 |
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants
|
Fontecha, María Belén
|
|
|
103 |
12 |
p. 5703-5712
|
artikel
|
| 52 |
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria
|
Dingli, David
|
|
|
103 |
12 |
p. 5213-5227
|
artikel
|
| 53 |
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial
|
Efficace, Fabio
|
|
|
103 |
12 |
p. 5341-5349
|
artikel
|
| 54 |
Hepatosplenic αβ T-cell lymphoma with peripheral blood involvement as initial presentation
|
Li, Ting
|
|
|
103 |
12 |
p. 6053-6055
|
artikel
|
| 55 |
Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report
|
Ahmad, Firoz
|
|
|
103 |
12 |
p. 5963-5971
|
artikel
|
| 56 |
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia
|
Toloza, María Jazmín
|
|
|
103 |
12 |
p. 5249-5260
|
artikel
|
| 57 |
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease
|
Lakhwani, Sunil
|
|
|
103 |
12 |
p. 5651-5661
|
artikel
|
| 58 |
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
|
Zha, Chenyu
|
|
|
103 |
12 |
p. 4883-4899
|
artikel
|
| 59 |
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry
|
Ekels, Afke
|
|
|
103 |
12 |
p. 5511-5525
|
artikel
|
| 60 |
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020
|
Teixeira, Marina Xavier
|
|
|
103 |
12 |
p. 5881-5889
|
artikel
|
| 61 |
Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation
|
McClellan, Kristen
|
|
|
103 |
12 |
p. 5351-5358
|
artikel
|
| 62 |
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab
|
Fadaos, Nashwa
|
|
|
103 |
12 |
p. 5861-5870
|
artikel
|
| 63 |
Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for β-thalassemia
|
Guo, Xianfeng
|
|
|
103 |
12 |
p. 5169-5179
|
artikel
|
| 64 |
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience
|
Lee, Benjamin J.
|
|
|
103 |
12 |
p. 5395-5403
|
artikel
|
| 65 |
Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia
|
He, Ying
|
|
|
103 |
12 |
p. 5285-5296
|
artikel
|
| 66 |
Ischemic stroke as a presenting feature of promyelocytic blast phase in chronic myeloid leukemia – an uncommon presentation: a case report and literature review in the post imatinib era
|
Tripathi, Swapnil
|
|
|
103 |
12 |
p. 6007-6013
|
artikel
|
| 67 |
Letter to the editor: adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in Thalassemia syndromes
|
Ahsan, Muhammad
|
|
|
103 |
12 |
p. 6039-6040
|
artikel
|
| 68 |
Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers
|
Eswaran, Harish
|
|
|
103 |
12 |
p. 5235-5239
|
artikel
|
| 69 |
Lymphocyte profile in peripheral blood of patients with multiple myeloma
|
Dekojová, Tereza
|
|
|
103 |
12 |
p. 5615-5625
|
artikel
|
| 70 |
MALAT1/miR-582-5p/GALNT1/MUC1 axis modulates progression of AML leukemia stem cells by regulating JAK2/STAT3 pathway
|
Li, Si
|
|
|
103 |
12 |
p. 5273-5283
|
artikel
|
| 71 |
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group
|
Forghieri, Fabio
|
|
|
103 |
12 |
p. 6045-6050
|
artikel
|
| 72 |
MDS patient registries - achievements and challenges
|
Steinmetz, Tilman
|
|
|
103 |
12 |
p. 4913-4930
|
artikel
|
| 73 |
Metabolic tumor volume from baseline [18 F]FDG PET/CT at diagnosis improves the IPI stratification in patients with diffuse large B-cell lymphoma
|
Zhang, Hanzhen
|
|
|
103 |
12 |
p. 5891-5902
|
artikel
|
| 74 |
MiR-525-5p modulates cell proliferation, cell cycle, and apoptosis in Burkitt’s lymphoma by targeting MyD88 and regulating the NF-κB signaling pathway
|
Chen, Yan
|
|
|
103 |
12 |
p. 5817-5833
|
artikel
|
| 75 |
M1 macrophage-derived exosomes alleviate leukemia by causing mitochondrial dysfunction
|
Li, Wenjuan
|
|
|
103 |
12 |
p. 5425-5438
|
artikel
|
| 76 |
Molecular insights into the hedgehog signaling pathway correlated non-coding RNAs in acute lymphoblastic leukemia, a bioinformatics study
|
Talebi, Elham
|
|
|
103 |
12 |
p. 5439-5447
|
artikel
|
| 77 |
mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review
|
Tanaka, Yuji
|
|
|
103 |
12 |
p. 4953-4969
|
artikel
|
| 78 |
Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG)
|
Zhu, Huayuan
|
|
|
103 |
12 |
p. 5713-5727
|
artikel
|
| 79 |
Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices
|
Lee, Jiyeon
|
|
|
103 |
12 |
p. 5749-5757
|
artikel
|
| 80 |
Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies
|
Hersby, Ditte Stampe
|
|
|
103 |
12 |
p. 5835-5848
|
artikel
|
| 81 |
Neutrophil extracellular traps - an a-list-actor in a variety of diseases
|
Wang, Na
|
|
|
103 |
12 |
p. 5059-5069
|
artikel
|
| 82 |
Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma
|
Tsukasaki, Hikaru
|
|
|
103 |
12 |
p. 5549-5555
|
artikel
|
| 83 |
Novel biallelic GNE variants identified in a patient with chronic thrombocytopenia without any symptoms of myopathy
|
Tsuda, Shota
|
|
|
103 |
12 |
p. 5945-5950
|
artikel
|
| 84 |
Novel serous effusion-related risk models and biomarkers for predicting prognosis in T-cell lymphoma patients
|
Shang, Juanjuan
|
|
|
103 |
12 |
p. 5557-5572
|
artikel
|
| 85 |
Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphoma
|
Colunga-Pedraza, Perla R.
|
|
|
103 |
12 |
p. 5607-5614
|
artikel
|
| 86 |
Overall survival in TP53-mutated AML and MDS
|
Puzo, Christian J.
|
|
|
103 |
12 |
p. 5359-5369
|
artikel
|
| 87 |
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes
|
Shah, Darshi
|
|
|
103 |
12 |
p. 5849-5859
|
artikel
|
| 88 |
Peculiar hyper vascular manifestations in idiopathic multicentric castleman disease without tafro syndrome: a case report
|
Jilani, Rahmeen Khisal
|
|
|
103 |
12 |
p. 5929-5934
|
artikel
|
| 89 |
Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas
|
Gaudio, Francesco
|
|
|
103 |
12 |
p. 5799-5805
|
artikel
|
| 90 |
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood
|
Kubota, Yusuke
|
|
|
103 |
12 |
p. 5989-5998
|
artikel
|
| 91 |
Pre-diagnostic trajectory of pediatric hemophagocytic lymphohistiocytosis: observations from hematological and hepatic parameters
|
Li, Xun
|
|
|
103 |
12 |
p. 5145-5155
|
artikel
|
| 92 |
Predictors for spontaneous remission in childhood chronic immune thrombocytopenia
|
Yang, Yuan-Ning
|
|
|
103 |
12 |
p. 5181-5189
|
artikel
|
| 93 |
Primary head and neck lymphoid neoplasms in adolescents and young adults: demographics, distribution and survival outcomes
|
Wei, Ming-Guang
|
|
|
103 |
12 |
p. 5871-5880
|
artikel
|
| 94 |
Prognosis of patients with Hodgkin lymphoma and indeterminate response to PD-1 inhibitor therapy: considerations for application of LYRIC criteria in real clinical practice
|
Fedorova, Liudmila
|
|
|
103 |
12 |
p. 5673-5680
|
artikel
|
| 95 |
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation
|
Cui, Kai
|
|
|
103 |
12 |
p. 5769-5780
|
artikel
|
| 96 |
Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis
|
Han, Xueya
|
|
|
103 |
12 |
p. 4943-4952
|
artikel
|
| 97 |
Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of menin-KMT2A inhibitor therapy for acute myeloid leukaemia
|
Tauveron-Jalenques, Urbain
|
|
|
103 |
12 |
p. 5985-5988
|
artikel
|
| 98 |
Racial and ethnic disparities in outcomes of diffuse large B cell lymphoma in adolescent and young adults: a SEER database analysis
|
Aqeel, Sheeba Ba
|
|
|
103 |
12 |
p. 5539-5547
|
artikel
|
| 99 |
Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators’ era
|
Pines, Morgan
|
|
|
103 |
12 |
p. 5229-5234
|
artikel
|
| 100 |
Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population
|
Lim, Ryan Mao Heng
|
|
|
103 |
12 |
p. 5483-5493
|
artikel
|
| 101 |
Reappraising the prognostic relevance of cytogenetic risk in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
|
Mizuno, Shohei
|
|
|
103 |
12 |
p. 5903-5913
|
artikel
|
| 102 |
Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia
|
Li, Yan
|
|
|
103 |
12 |
p. 5599-5605
|
artikel
|
| 103 |
Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury
|
Fan, Lulu
|
|
|
103 |
12 |
p. 5925-5927
|
artikel
|
| 104 |
Successful treatment with Pola-R-mini-CHP for elderly relapsed and refractory mantle cell lymphoma
|
Oka, Satoko
|
|
|
103 |
12 |
p. 5981-5983
|
artikel
|
| 105 |
Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists
|
Blankstein, Anna R.
|
|
|
103 |
12 |
p. 5371-5376
|
artikel
|
| 106 |
Survival impact of hypoxia-inducible factor-1 alpha (HIF-1α) in Nucleophosmin1 mutated acute myeloid leukemia
|
Chanswangphuwana, Chantiya
|
|
|
103 |
12 |
p. 5417-5423
|
artikel
|
| 107 |
The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia
|
Yang, Li
|
|
|
103 |
12 |
p. 5449-5460
|
artikel
|
| 108 |
The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
|
Sun, Lin
|
|
|
103 |
12 |
p. 5157-5168
|
artikel
|
| 109 |
The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients
|
Shimazu, Yutaka
|
|
|
103 |
12 |
p. 5639-5649
|
artikel
|
| 110 |
The prognostic significance of genetics in acute myeloid leukemia under venetoclax-based treatment
|
Zheng, Shan
|
|
|
103 |
12 |
p. 5019-5033
|
artikel
|
| 111 |
Therapy-related myeloid neoplasms: a real-world pharmacovigilance analysis (1970–2023)
|
Gaddam, Shiva Jashwanth
|
|
|
103 |
12 |
p. 6051-6052
|
artikel
|
| 112 |
The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic biomarkers of acute myeloid leukemia
|
Atnaf, Aytenew
|
|
|
103 |
12 |
p. 4931-4942
|
artikel
|
| 113 |
The second adult case of NUTM1 fusion-positive B-cell lymphoblastic leukemia: A recurring pattern of poor prognosis
|
Chen, Xue
|
|
|
103 |
12 |
p. 6041-6043
|
artikel
|
| 114 |
Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry
|
Tirachotikul, Thitirat
|
|
|
103 |
12 |
p. 5741-5748
|
artikel
|
| 115 |
T(11;14) with multiple myeloma: Standard risk survival but slow and poor response
|
Liu, Yuntong
|
|
|
103 |
12 |
p. 5573-5581
|
artikel
|
| 116 |
Update on kidney injury caused by multiple myeloma
|
Wang, Linhui
|
|
|
103 |
12 |
p. 5007-5018
|
artikel
|
| 117 |
Using machine learning approaches to develop a fast and easy-to-perform diagnostic tool for patients with light chain amyloidosis: a retrospective real-world study
|
Liu, Yang
|
|
|
103 |
12 |
p. 5781-5798
|
artikel
|
| 118 |
Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia
|
Kontandreopoulou, Christina-Nefeli
|
|
|
103 |
12 |
p. 4971-4980
|
artikel
|
| 119 |
Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study
|
Ma, Hongbing
|
|
|
103 |
12 |
p. 5315-5323
|
artikel
|
| 120 |
Virus-driven dysregulation of the BCR pathway: a potential mechanism for the high prevalence of HIV related B-cell lymphoma
|
Liang, Ying
|
|
|
103 |
12 |
p. 4839-4849
|
artikel
|
Tijdschrift beschrijving